STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

ABVX holder files Form 144 to sell 1.2M ADS on NASDAQ

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ABVX: A stockholder filed a Form 144 to sell up to 1,200,000 ADS, with an aggregate market value of $111,300,000. The proposed sale is listed for approximately 10/28/2025 through Leerink Partners on the NASDAQ.

The securities were acquired in the IPO on 10/20/2023, with 1,200,000 ADS purchased from the issuer and paid in cash on 10/24/2023. Shares outstanding were 77,800,000; this is a baseline figure, not the amount being offered.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did ABVX disclose in this Form 144?

A holder filed notice to sell up to 1,200,000 ADS on or about 10/28/2025.

What is the aggregate market value of the proposed ABVX sale?

The filing lists an aggregate market value of $111,300,000 for the 1,200,000 ADS.

Which broker and exchange are involved for ABVX?

The broker is Leerink Partners, and the shares are to be sold on NASDAQ.

When and how were the ABVX shares acquired?

They were purchased in the IPO on 10/20/2023 and paid in cash on 10/24/2023.

How many ABVX shares are outstanding?

The filing lists 77,800,000 shares outstanding.

What class of ABVX securities is included in the Form 144?

The filing covers ADS (American Depositary Shares).
Abivax S.A.

NASDAQ:ABVX

ABVX Rankings

ABVX Latest News

ABVX Latest SEC Filings

ABVX Stock Data

10.37B
77.83M
43.25%
2.15%
Biotechnology
Healthcare
Link
France
Paris